Peter Young

Peter is an experienced life-science industry consultant and executive-in-residence with Pappas Capital, where he leads the firm’s initiatives in translational medicine and is the Program Manager for the Wake Forest Technology Development Program. Peter has over thirty-five years’ experience in the pharmaceutical and biotech industry, spanning all areas of the business from sales representative to country-level general manager and CEO and companies ranging from multinationals like Abbott and Glaxo to start-up biotechs.

At Glaxo Wellcome in the mid-1990s, he led the global introduction of combination HIV therapy while keying industry leadership on global treatment access. Peter currently serves on the Oversight Committee for the University of Miami Wallace H. Coulter Center for Translational Research and as an Executive in Residence at Cold Spring Harbor Laboratories and the Center for Biotechnology at Stony Brook University. He is a member of the Long Island Bioscience Hub External Review Board and the Long Island Biomentor Initiative, a past member of the BIO board and chairman of the North Carolina Biosciences Organization, and director of Memory Pharmaceuticals from 2004 until its sale to Roche in 2009. He has lived and worked in the US, Greece and the Middle East, Puerto Rico, New Zealand, and London, and currently lives with his family in New York. He has a BA and an MBA from Indiana University.